Medicine Patents that Are Among the Most Sold in the Country Will Fall in 2026

Revista Oeste

Factuality

Ownership

The new Nordisk laboratory, manufacturer of Ozempic and Wegovy, sought to extend the patent of semagutida — the active principle of the two substances — beyond 2026. The application had already been rejected in lower courts and, since April, waits for Minister Maria Isabel Gallotti's decision. The registration of the Danish pharmaceutical patent expires on 20 March 2026. Since 2021, the company has tried to extend this period. The main argument …

Globo

Factuality

Ownership

In the coming year, the patents will fall from nine of the 20 medicines most prescriptions given to their manufacturers in Brazil. They represent R$ 6.8 billion per year in invoice, according to the IQVIA consultancy. Unique material for signatories. To have complete access, access the material link and make your daughter.